GlassScriptPhysician profile
Katherine Kunkel
NPI 1538502562
$188,689.87
in general payments reported to CMS, 2019-2025
31 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,679 · 2020: $24K · 2021: $1,864 · 2022: $37K · 2023: $72K · 2024: $37K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $64K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Travel and Lodging: $14K · Consulting Fee: $13K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,700 · Food and Beverage: $2,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $64,050.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,100.00 |
| Travel and Lodging | $13,893.62 |
| Consulting Fee | $13,287.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,700.00 |
| Food and Beverage | $2,882.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $76,703.92 | 2019-2024 | Impella |
| Medtronic, INC. | $49,224.06 | 2022-2025 | Symplicity G3, Onyx Frontier |
| Boston Scientific Corporation | $22,052.96 | 2019-2025 | General - Therapies, Rotapro, Avvigo Guidance System |
| Cardiovascular Systems INC. | $16,437.55 | 2019-2023 | Diamondback Peripheral, Diamondback Coronary |
| Abbott Laboratories | $7,975.94 | 2020-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $4,684.80 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Medtronic Vascular, INC. | $3,412.50 | 2019-2020 | |
| Biotronik INC. | $2,383.26 | 2021-2025 | Pk Papyrus |
| Janssen Global Services, LLC | $2,020.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $665.24 | 2022-2025 | |
| Edwards Lifesciences Corporation | $614.19 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $568.17 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $439.68 | 2019-2022 | |
| Teleflex LLC | $337.75 | 2022-2024 | Guideliner |
| Zoll Circulation INC | $274.10 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $182.19 | 2023-2024 | Alphavac |
| Bard Peripheral Vascular, INC. | $150.00 | 2019 | |
| Siemens Medical Solutions USA, INC. | $120.11 | 2020 | |
| Amgen INC. | $109.89 | 2024-2025 | Repatha, Repatha |
| Philips North America LLC | $74.11 | 2022 | |
| W. L. Gore & Associates, INC. | $66.00 | 2019 | |
| Asahi Intecc USA, INC. | $43.89 | 2023 | Asahi Ptca Guide Wire |
| E.R. Squibb & Sons, L.L.C. | $36.53 | 2025 | Eliquis |
| Cardiva Medical, INC. | $26.24 | 2024 | Optowire |
| Heartflow, INC. | $20.43 | 2023 | Ffrct |
| Pfizer INC. | $19.96 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.10 | 2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $15.62 | 2021 | |
| Cordis US Corp. | $14.68 | 2024 | Selution Slrpta |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Kunkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.